Starship shows what the entrepreneur can achieve when he sticks to what he does best
Genetic largesse from some of Silicon Valley’s elite appears to be a mix of narcissism, altruism and dreams of immortality
Losses widen at Isomorphic Labs, as new Nobel Prize winner pushes forward with effort to use AI in healthcare
Successful test is step forward in billionaire’s bid to create fully reusable spacecraft
Awards for Sir Demis Hassabis, John Jumper and Geoffrey Hinton recognise how AI is changing our world
Proof-of-concept funding is alarmingly scarce but can drive up the success rate of innovative ideas
Award for Sir Demis Hassabis, John Jumper and David Baker recognises advances in unlocking proteins’ secrets
It is too early to know whether the prompt response to the virus is enough to turn the tide
The FT’s senior science writer explores how far we can go
Geoffrey Hinton, co-recipient of award with John Hopfield, warns of potential dangers of the technology
Regulatory Innovation Office will take innovation ‘by scruff of neck’, says science secretary Peter Kyle
Victor Ambros and Gary Ruvkun discovered microRNA and its role in how organisms develop and function
Lessons from cuckoos, caterpillars and tortoises: the influential biologist’s new book ‘reads’ genes as palimpsests of the past
Developments in materials and techniques allow for ever-brighter and unusual timepieces
International collaboration plotted 149 metres of biological wiring in fruit fly
From climate change to crime, repositories of good quality information are essential
Artificial intelligence used to help researchers plan experiments and better predict outcomes
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
Money needed to kick-start project that will rival renowned schemes in Paris and Massachusetts
Warming of 1.5C to 3C will lead to droughts and heatwaves requiring greater use of air-conditioning systems
The next stage in the war on cancer may be enlisting patients’ own blood cells to fight the disease
The reduced effectiveness of antibiotics risks severe disruption to the global economy
The lessons learnt from drug-resistant tuberculosis offer a path to beating back the ‘silent pandemic’ of antimicrobial resistance
Emmanuel Hanon criticises former company’s drug after he raises $100mn for rival product
But the healthcare system in the US still struggles to provide adequate care for those with serious mental illness
